Published in Exp Ther Med on April 09, 2015
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int (2009) 4.02
Molecular basis of renal fibrosis. Pediatr Nephrol (2000) 2.71
Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol (2004) 2.64
Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ (2004) 2.39
Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum Mol Genet (2008) 1.98
Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int (2006) 1.91
Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant (2001) 1.69
Immunohistochemistry and quantitative analysis of protein expression. Arch Pathol Lab Med (2006) 1.65
Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med (2004) 1.59
Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. Am J Physiol Cell Physiol (2013) 1.57
Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model. Nephrol Dial Transplant (2008) 1.55
Molecular mechanisms and physiologic functions of mitochondrial dynamics. J Biochem (2011) 1.55
Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol (2009) 1.53
SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. FASEB J (2009) 1.45
Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis. Am J Physiol Cell Physiol (2010) 1.36
Unilateral ureteral obstruction: beyond obstruction. Int Urol Nephrol (2013) 1.09
TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast. Biochim Biophys Acta (2013) 1.00
Protective effect of erythropoietin on renal ischemia and reperfusion injury. ANZ J Surg (2005) 0.99
Antifibrotic properties of relaxin: in vivo mechanism of action in experimental renal tubulointerstitial fibrosis. Endocrinology (2010) 0.96
Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury. Kidney Int (2012) 0.94
Erythropoietin mimics ischemic preconditioning. Vascul Pharmacol (2005) 0.94
Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies. Transl Res (2007) 0.90
Protective effect of erythropoietin pretreatment in testicular ischemia-reperfusion injury in rats. J Pediatr Surg (2008) 0.89
TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation. Kidney Int (2012) 0.89
Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. Kidney Int (2000) 0.88
Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction. Clin Transplant (2009) 0.88
Erythropoietin attenuates renal injury in an experimental model of rat unilateral ureteral obstruction via anti-inflammatory and anti-apoptotic effects. J Urol (2009) 0.86
Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction? Int J Urol (2008) 0.84
Obstructive renal injury: from fluid mechanics to molecular cell biology. Open Access J Urol (2010) 0.84
Recombinant human erythropoietin attenuates renal tubulointerstitial injury in murine adriamycin-induced nephropathy. J Nephrol (2012) 0.80
Association of angiotensinogen gene polymorphism with erythropoietin-induced hypertension: a preliminary report. Hypertens Res (2001) 0.77